Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Improved assessment of arterial stiffness using corrected cardio-ankle vascular index (CAVI0) in overweight adolescents with white-coat and essential hypertension

M. Mestanik, A. Jurko, B. Spronck, AP. Avolio, M. Butlin, T. Jurko, Z. Visnovcova, A. Mestanikova, P. Langer, I. Tonhajzerova,

. 2017 ; 77 (8) : 665-672. [pub] 20171106

Language English Country England, Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc18033594

Arterial stiffness is a marker of vascular damage. Although adiposity increases cardiovascular risk, the relationship between paediatric overweight and arterial stiffness is unclear. The study aimed to evaluate the simultaneous effect of hypertension and overweight on arterial stiffness using cardio-ankle vascular index (CAVI) and related novel, theoretically blood pressure (BP)-independent, index CAVI0. CAVI and CAVI0 were measured in 140 adolescent boys (16.0 ± 1.9 years) divided into age-matched groups: normal-weight normotensives, overweight normotensives, overweight white-coat hypertensives, and overweight essential hypertensives. Overweight normotensives had significantly lower CAVI and CAVI0 compared to normal-weight normotensives (4.81 ± 0.64 vs. 5.33 ± 0.66, p < .01; 7.10 ± 0.99 vs. 7.81 ± 1.00, p < .01, respectively). CAVI and CAVI0 in overweight essential hypertensives showed no significant difference compared to normal-weight normotensives and were significantly higher compared to overweight normotensives (5.32 ± 0.77 vs. 4.81 ± 0.64, p < .01; 7.77 ± 1.19 vs. 7.10 ± 0.99, p < .01, respectively). CAVI, but not CAVI0, was associated positively with diastolic pressure (0.022 mmHg-1, p = .002) and negatively with pulse pressure (-0.022 mmHg-1, p = .001), and it was significantly higher in overweight white-coat hypertensives compared to overweight normotensives (5.20 ± 0.63 vs. 4.81 ± 0.64, p < .05). The lowering effect of overweight on arterial stiffness indexed by CAVI and CAVI0 in hypertensive adolescents seems to counterbalance the early arteriosclerotic effect of essential hypertension. The increase in CAVI, but not CAVI0, in overweight white-coat hypertensives could be attributable to residual BP dependence of CAVI, which is not present in CAVI0. Under certain conditions, CAVI0 may offer a clinically relevant improved assessment of arterial stiffness superior to CAVI.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18033594
003      
CZ-PrNML
005      
20181015113534.0
007      
ta
008      
181008s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/00365513.2017.1397286 $2 doi
035    __
$a (PubMed)29103321
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Mestanik, Michal $u a Biomedical Center Martin , Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin (JFM CU) , Martin , Slovak Republic. b Department of Physiology , JFM CU , Martin , Slovak Republic.
245    10
$a Improved assessment of arterial stiffness using corrected cardio-ankle vascular index (CAVI0) in overweight adolescents with white-coat and essential hypertension / $c M. Mestanik, A. Jurko, B. Spronck, AP. Avolio, M. Butlin, T. Jurko, Z. Visnovcova, A. Mestanikova, P. Langer, I. Tonhajzerova,
520    9_
$a Arterial stiffness is a marker of vascular damage. Although adiposity increases cardiovascular risk, the relationship between paediatric overweight and arterial stiffness is unclear. The study aimed to evaluate the simultaneous effect of hypertension and overweight on arterial stiffness using cardio-ankle vascular index (CAVI) and related novel, theoretically blood pressure (BP)-independent, index CAVI0. CAVI and CAVI0 were measured in 140 adolescent boys (16.0 ± 1.9 years) divided into age-matched groups: normal-weight normotensives, overweight normotensives, overweight white-coat hypertensives, and overweight essential hypertensives. Overweight normotensives had significantly lower CAVI and CAVI0 compared to normal-weight normotensives (4.81 ± 0.64 vs. 5.33 ± 0.66, p < .01; 7.10 ± 0.99 vs. 7.81 ± 1.00, p < .01, respectively). CAVI and CAVI0 in overweight essential hypertensives showed no significant difference compared to normal-weight normotensives and were significantly higher compared to overweight normotensives (5.32 ± 0.77 vs. 4.81 ± 0.64, p < .01; 7.77 ± 1.19 vs. 7.10 ± 0.99, p < .01, respectively). CAVI, but not CAVI0, was associated positively with diastolic pressure (0.022 mmHg-1, p = .002) and negatively with pulse pressure (-0.022 mmHg-1, p = .001), and it was significantly higher in overweight white-coat hypertensives compared to overweight normotensives (5.20 ± 0.63 vs. 4.81 ± 0.64, p < .05). The lowering effect of overweight on arterial stiffness indexed by CAVI and CAVI0 in hypertensive adolescents seems to counterbalance the early arteriosclerotic effect of essential hypertension. The increase in CAVI, but not CAVI0, in overweight white-coat hypertensives could be attributable to residual BP dependence of CAVI, which is not present in CAVI0. Under certain conditions, CAVI0 may offer a clinically relevant improved assessment of arterial stiffness superior to CAVI.
650    _2
$a mladiství $7 D000293
650    _2
$a kotník $x krevní zásobení $7 D000842
650    _2
$a arterioskleróza $x diagnóza $7 D001161
650    _2
$a krevní tlak $7 D001794
650    _2
$a lidé $7 D006801
650    _2
$a hypertenze $x diagnóza $7 D006973
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a nadváha $x patologie $x patofyziologie $7 D050177
650    _2
$a analýza pulzové vlny $7 D063177
650    _2
$a zlepšení kvality $7 D058996
650    _2
$a rizikové faktory $7 D012307
650    _2
$a tuhost cévní stěny $7 D059289
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jurko, Alexander $u c Paediatric Cardiology , Martin , Slovak Republic.
700    1_
$a Spronck, Bart $u d Department of Biomedical Sciences, Faculty of Medicine and Health Sciences , Macquarie University , Sydney , NSW , Australia.
700    1_
$a Avolio, Alberto P $u d Department of Biomedical Sciences, Faculty of Medicine and Health Sciences , Macquarie University , Sydney , NSW , Australia.
700    1_
$a Butlin, Mark $u d Department of Biomedical Sciences, Faculty of Medicine and Health Sciences , Macquarie University , Sydney , NSW , Australia.
700    1_
$a Jurko, Tomas $u e Clinic of Neonatology , JFM CU, University Hospital Martin , Martin , Slovak Republic.
700    1_
$a Visnovcova, Zuzana $u a Biomedical Center Martin , Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin (JFM CU) , Martin , Slovak Republic. b Department of Physiology , JFM CU , Martin , Slovak Republic.
700    1_
$a Mestanikova, Andrea $u a Biomedical Center Martin , Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin (JFM CU) , Martin , Slovak Republic. b Department of Physiology , JFM CU , Martin , Slovak Republic.
700    1_
$a Langer, Peter $u f Institute of Scientific Instruments, The Czech Academy of Sciences , Brno , Czech Republic. g International Clinical Research Center , St. Anne's University Hospital Brno , Brno , Czech Republic.
700    1_
$a Tonhajzerova, Ingrid $u a Biomedical Center Martin , Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin (JFM CU) , Martin , Slovak Republic. b Department of Physiology , JFM CU , Martin , Slovak Republic.
773    0_
$w MED00010597 $t Scandinavian journal of clinical and laboratory investigation $x 1502-7686 $g Roč. 77, č. 8 (2017), s. 665-672
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29103321 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20181015114030 $b ABA008
999    __
$a ok $b bmc $g 1340218 $s 1030588
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 77 $c 8 $d 665-672 $e 20171106 $i 1502-7686 $m Scandinavian journal of clinical & laboratory investigation $n Scand J Clin Lab Invest $x MED00010597
LZP    __
$a Pubmed-20181008

Find record

Citation metrics

Archiving options